AAN 2021

sNfL projects development of definite MS

In patients who experienced a first clinical demyelinating event, baseline levels of serum neurofilament light chain (sNfL), a biomarker of neural damage, were associated with conversion to McDonald 2005 multiple sclerosis (MS)....

Read More

2021 AAN Annual Meeting Kick-Off!

Due to the COVID-19 pandemic, the 2021 American Academy of Neurology Annual Meeting, the world’s premier neurology meeting, will be held in a fully virtual format from April 17-22. It will include: Over 90 expert-led CME...

Read More

AAN 2021: Dual Tasking In Patients With MS

Patients with MS may have difficulty performing double task (DT) while walking or causing interference. More research is needed in order to define the role of disability degree in the severity of the interference produced in the...

Read More

PhysQuiz Answers! AAN 2021: Multiple Sclerosis

Which of the following is a preliminary outcome of the retrospective, multi-center observational study in a cohort of Italian MS patients investigating the impact of disease-modifying treatments on COVID-19 course of disease?a)...

Read More
  • 1
  • 2

For latest news and updates
Email-id is invalid